SAMARITAN PHARMACEUTICALS INC 4
4 · SAMARITAN PHARMACEUTICALS INC · Filed Aug 11, 2008
Insider Transaction Report
Form 4
GREESON JANET
DirectorChief Executive Officer
Transactions
- Award
Stock Options (right to buy)
2008-08-07+60,000→ 60,000 total(indirect: NextGen LifeSciences Inc.)Exercise: $0.25From: 2008-08-07Exp: 2010-08-07→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]Option exercise price was above the underlying stock price on grant date.